Predictors and Long-term Prognosis of Angiographic Slow/No-Reflow Phenomenon During Emergency Percutaneous Coronary Intervention for ST-Elevated Acute Myocardial Infarction-Reference-Cited by-同舟云学术

Predictors and Long-term Prognosis of Angiographic Slow/No-Reflow Phenomenon During Emergency Percutaneous Coronary Intervention for ST-Elevated Acute Myocardial Infarction

Published:2010-12 Issue:12 Volume:33 Page:E7-E12
ISSN:0160-9289
Container-title:Clinical Cardiology
language:en
Short-container-title:Clin Cardiol

Author:

Dong-bao Li,Qi Hua,Zhi Liu,Shan Wang,Wei-ying Jin

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/clc.20634/fullpdf

Reference31 articles.

1. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review;Weawer;JAMA,1997

2. Primary angioplasty versus thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomized trials;Keeley;Lancet,2003

3. Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group;Grines;N Engl J Med,1999

4. Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction;Morishima;J Am Coll Cardiol,2000

5. Acute hyperglycemia is associated with adverse outcome after acute myocardial infarction in the coronary intervention era;Ishihara;Am Heart J,2005

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of orphan G-protein coupled receptors in tissue ischemia: A comprehensive review;European Journal of Pharmacology;2024-09

2. The Evolving Status of Cavitation Therapy in Acute Myocardial Infarction;Journal of the American Society of Echocardiography;2024-07

3. No-Reflow Prediction in Acute Coronary Syndrome During Percutaneous Coronary Intervention: The NORPACS Risk Score;Circulation: Cardiovascular Interventions;2024-04

4. A biomarker for estimating no-reflow phenomenon in PCI-treated non-ST-segment elevation myocardial infarction patients: serum Cystatin C;Anatolian Current Medical Journal;2024-03-08

5. Impact of HAT₂CH₂ Score on the Development of No-Reflow Phenomenon in Patients With ST-Segment Elevation Myocardial Infarction;Angiology;2023-05-30